Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by Lobe Sciences Ltd. and Virtual Psychedelics Incorporated, Appointment of Interdisciplinary Team of Advisors
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Krysalis VX Innovations Inc. ("Krysalis"), the Virtual experience ("VX")-focused company designing the delivery of immersive, headset-free experiences through the KrysalisTM Pod system that will offer treatment options for cognitive, psychological, motor and functional impairments across various clinical health conditions, has...
2021-10-06 8:45 AM EDT
Lobe Sciences to Present at the BioFuture 2021 & MoneyShow Virtual Expo Investor Conferences
Vancouver, British Columbia--(Newsfile Corp. - October 5, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present virtually at the BioFuture 2021 Conference taking place October 5-6, 2021, and will present virtually at the MoneyShow Virtual Expo taking place October 5-7, 2021Philip Young, CEO and Director, will have his presentation streamed throughout the conference at the Lobe virtual booth during...
2021-10-05 8:45 AM EDT
Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD
Plans to Develop and Launch A Global Registry For The Identification and Long Term Management of Current and Former Boxers With mTBI and PTSDInsights Derived From This Project Will Help Guide The Development Of Guidelines and Treatment Goals For The WBA FamilyVancouver, British Columbia--(Newsfile Corp. - October 4, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that the Company plans to develop and launch a global registry for the...
2021-10-04 8:30 AM EDT
Lobe Sciences to Present at the Benzinga Healthcare Small Cap Conference
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present virtually at the Benzinga Healthcare Small Cap Conference taking place September 29-30, 2021.Philip Young, CEO and Director will begin his presentation at 10:30 A.M. ET on Wednesday, September 29, 2021. The event is accessible using the following link:...
2021-09-27 8:45 AM EDT
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
Vancouver, British Columbia--(Newsfile Corp. - September 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will participate in a round table discussion at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference presented by Maxim Group and hosed by M-Vest taking place Sept. 22, 2021.The discussion will focus on the topics surrounding Deliver, Manufacturing, & Technology and "What does...
2021-09-15 9:02 AM EDT
Lobe Sciences Provides Corporate Update to Investors and Stakeholders
Vancouver, British Columbia--(Newsfile Corp. - September 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to provide the following corporate update by CEO Philip Young, addressed to shareholders, investors and other stakeholders of the Company:Dear Fellow Shareholders and Psychedelic Medicine Enthusiasts,We are pleased to say that 2021 has been a busy and transformative year for the Company. During 2021, we have made significant progress on...
2021-09-13 9:43 AM EDT
Lobe Sciences to Present At H.C. Wainwright 23rd Annual Global Investment Conference
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present at the H.C. Wainwright 23rd Annual Global Investor Conference taking place Sept. 13-15, 2021.The presentation will be available on demand through the H.C. Wainwright conference portal, beginning at 7:00 a.m. ET on Monday, Sept. 13, 2021. Registration for the event is accessible via...
2021-09-10 8:15 AM EDT
Lobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory Board
Medical Virtual Reality - Institute for Creative Technologies Research Professor - Dept. of Psychiatry and School of Gerontology University of Southern CaliforniaVancouver, British Columbia--(Newsfile Corp. - August 23, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Albert "Skip" Rizzo, Ph.D, to its Scientific Advisory Board.Philip Young, CEO and Director of Lobe stated, "We are extremely happy to have an industry...
2021-08-23 8:45 AM EDT
Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - July 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Gilberto Jesús Mendoza, President of the World Boxing Association, to its Advisory Board.Philip Young, CEO and Director of Lobe stated, "We are privileged to welcome Gilberto to our Advisory Board and the Lobe family. We all take the maintenance and treatment to improve brain and mental health as a priority. ...
2021-07-13 8:00 AM EDT
Lobe Sciences Clarifies Recent Promotional Activities at Request of OTC Markets
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that it became aware of certain promotional activities concerning its common stock on June 10, 2021. Issuer Services at OTC Markets Group (OTC Markets) notified the Company and supplied one (1) electronic newsletter (the "Newsletter") prepared by a third party - HotOtc as an example of such promotion. The Company was not aware of such...
2021-07-02 5:05 PM EDT
Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board
David Geffen School of Medicine at UCLA Vancouver, British Columbia--(Newsfile Corp. - June 28, 2021) - Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the appointment of Charles Grob, MD Investigator, The Lundquist Institute, and Professor of Psychiatry & Biobehavioral Sciences and Pediatrics, David Geffen School of Medicine at UCLA, to its Advisory Board.Philip Young, CEO and Director of Lobe stated,...
2021-06-28 8:45 AM EDT
Lobe Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today that Philip Young, CEO and Director will be presenting virtually at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference taking place on Thursday, June 17, 2021.H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference Details:Date: Thursday, June 17, 2021Registration & Webcast:...
2021-06-15 8:45 AM EDT
Lobe Sciences to Present at the LD Micro Invitational XI
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today that it will be presenting virtually at the LD Micro Invitational XI Conference taking place on Tuesday, June 8th through Thursday, June 10th 2021. Philip Young, CEO and Director will be presenting on Tuesday, June 8th at 5:30 PM ET.Event: Lobe Sciences Presentation at the LD Micro Invitational XIDate: Tuesday, June 8th, 2021 Time: 5:30 PM...
2021-06-07 4:05 PM EDT
Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce it has entered into a production and supply agreement (the "Agreement") on May 14, 2021 with HAVN Life Sciences Inc. (CSE: HAVN) (OTC Pink: HAVLF) (FSE: 5NP) ("HAVN"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products.Pursuant to the Agreement, HAVN...
2021-05-19 8:45 AM EDT
Lobe Sciences to Present at the Benzinga Global Small Cap Conference
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it will be presenting at the Benzinga Global Small Cap Conference taking place on May 13-14, 2021. Philip Young, CEO and Director will be presenting on Thursday May 13th at 12:25 pm ET.Philip Young, CEO and Director of Lobe, stated, "We look forward to discussing the latest developments and opportunities ahead of us as we continue...
2021-05-06 8:30 AM EDT
Lobe Sciences Acquires Vitamind Line of Wellness Products
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has acquired, through its wholly owned subsidiary Eleusian Biosciences Corp. ("Eleusian"), the consumer goods product line, "Vitamind", pursuant to an asset purchase agreement (the "Purchase Agreement") dated April 30, 2021 between Eleusian and a holding corporation which holds the rights to Vitamind (the "Vendor") (the...
2021-05-04 8:30 AM EDT
Lobe Sciences Announces Filing of PCT Application
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the filing of a key Patent Cooperation Treaty ("PCT") application entitled Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder.Philip Young, CEO and Director of Lobe stated, "We are committed to pursuing patent...
2021-04-29 8:45 AM EDT
Lobe Sciences Enters into LOI with Core One Labs to Form a Joint Venture for the Clinical Development of Biosynthetic Psilocybin
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce it has entered into a non-binding letter of intent dated April 27, 2021 (the "Agreement") with Core One Labs Inc. (CSE: COOL) ("Core One Labs") to pursue the formation of a joint venture involving the development, regulatory approval and marketing of biosynthetic psilocybin and other psychedelic compounds (the "Joint Venture")....
2021-04-28 8:45 AM EDT
Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has entered into an agreement dated April 26th, 2021 with Virtual Psychedelics Incorporated ("VPI") and certain industry-leading pioneers, including Hollywood director Brett Leonard and researcher and USC professor Dr. Skip Rizzo, with respect to the joint design, development and commercialization of a new...
2021-04-27 8:45 AM EDT
Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.Philip Young, CEO and Director of Lobe stated, "We are extremely pleased to welcome Ben to our Scientific Advisory Board. Dr. Kelmendi will add significant relevant experience to the...
2021-04-20 8:45 AM EDT